...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** BETonMACE Phase 3 Cardio Outcomes Trial for Apabetalone Has Reached its Targeted 250 MACE Events ** Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Free
Message: Booyah ! I told you all!!

Agreed Bfw. EagleEyeCap's last post was logged as a violation of Agoracom rules and he/she has been warned. Proximity to database lock has no bearing on success or failure of BETonMACE. Back on April 18th, Resverlogix expected 2 to 4 months for trial wrap up. We aren't even a month in yet. Seems like EagleEye is showing his/her true colors.

BearDownAZ

Share
New Message
Please login to post a reply